Comparison of choline and pharmacokinetic parameters in breast cancer measured by MR spectroscopic imaging and dynamic contrast enhanced MRI

被引:0
|
作者
Su, Min-Ying [1 ]
Baik, Hyun-Man
Yu, Hon J.
Chen, Jeon-hor
Mehta, Rita S.
Nalcioglu, Orhan
机构
[1] Univ Calif Irvine, John Tu & Thomas Yuen Ctr Funct Oncoimaging, Irvine, CA 92697 USA
[2] Univ Calif Irvine, Dept Med, Irvine, CA 92697 USA
关键词
breast cancer; choline; dynamic contrast enhanced MRI; MR spectroscopic imaging; neoadjuvant chemotherapy; and pharmacokinetic parameters;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Although an MRI scanner is a single stand-alone modality, different acquisition techniques may be applied to collect structural and functional information, including vascular or angiogenic properties measured by dynamic contrast enhanced MRI (DCE-MRI) and Choline (Cho) metabolism measured by proton MR spectroscopy imaging (MRSI). They may provide complementary information for a better characterization of neoplasm. In this study, we investigated the correlation between Choline measured by MRSI and vascular parameters measured by DCE-MRI in breast cancer. Fourteen patients with histologically proven invasive breast cancer were included. MRSI from a grid of 8 x 8 voxels within a selected slab from each lesion was performed. Each voxel was 1.0 x 1.0 x 1.2 cm(3). Choline signal-to-noise ratio (SNR) was measured from each voxel showing an identifiable Choline peak. Corresponding DCE kinetics was measured from each voxel, and analyzed with a 2-compartmental model to obtain pharmacokinetic parameters K-trans and k(ep). All parameters showed a wide variation within each lesion, and there were no consistent correlations between regional Cho and DCE parameters within the lesion of each individual patient. This finding might be attributed to the heterogeneous nature of breast cancer. The characteristic Cho and DCE-MRI parameters were obtained for each patient by averaging over all Cho-positive voxels. In these 14 patients there was a significant linear correlation between Cho with percent enhancement at 2 min after injection, SE%-2min (r = 0.75, p = 0.002), and pharmacokinetic parameters K-trans (r = 0.74, p = 0.003), and k(ep) (r = 0.76, p = 0.002). The results suggested that overall there is a correlation between Choline metabolism and angiogenesis activity. Since Choline is associated with cell replication and angiogenesis is required to support tumor growth, this might explain the correlation between these two sets of measures among different lesions.
引用
收藏
页码:401 / 410
页数:10
相关论文
共 50 条
  • [21] Accurate estimation of pharmacokinetic contrast-enhanced dynamic MRI parameters of the prostate
    Huisman, HJ
    Engelbrecht, MR
    Barentsz, JO
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2001, 13 (04) : 607 - 614
  • [22] Multiparametric MR imaging of the breast with dynamic contrast-enhanced MR imaging, diffusion-weighted imaging and proton MR spectroscopy: Are all three parameters necessary for accurate breast cancer diagnosis?
    Pinker-Domenig, K.
    Bogner, W.
    Gruber, S.
    Dubsky, P. C.
    Bago-Horvath, Z.
    Bartsch, R.
    Helbich, T.
    CANCER RESEARCH, 2013, 73
  • [23] Measurement of pharmacokinetic parameters in histologically graded invasive breast tumours using dynamic contrast-enhanced MRI
    Radjenovic, A.
    Dall, B. J.
    Ridgway, J. P.
    Smith, M. A.
    BRITISH JOURNAL OF RADIOLOGY, 2008, 81 (962): : 120 - 128
  • [24] Pharmacokinetic parameters and radiomics model based on dynamic contrast enhanced MRI for the preoperative prediction of sentinel lymph node metastasis in breast cancer
    Liu, Meijie
    Mao, Ning
    Ma, Heng
    Dong, Jianjun
    Zhang, Kun
    Che, Kaili
    Duan, Shaofeng
    Zhang, Xuexi
    Shi, Yinghong
    Xie, Haizhu
    CANCER IMAGING, 2020, 20 (01)
  • [25] Pharmacokinetic parameters and radiomics model based on dynamic contrast enhanced MRI for the preoperative prediction of sentinel lymph node metastasis in breast cancer
    Meijie Liu
    Ning Mao
    Heng Ma
    Jianjun Dong
    Kun Zhang
    Kaili Che
    Shaofeng Duan
    Xuexi Zhang
    Yinghong Shi
    Haizhu Xie
    Cancer Imaging, 20
  • [26] Comparison of three physiologically-based pharmacokinetic models for the prediction of contrast agent distribution measured by dynamic MR imaging
    Barboriak, Daniel P.
    MacFall, James R.
    Viglianti, Benjamin L.
    Dewhirst, Mark W.
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2008, 27 (06) : 1388 - 1398
  • [27] Dynamic versus static analysis in contrast enhanced MR imaging of the breast
    Teubner, JK
    Peitgen, H
    Dorn, T
    Walz, M
    Weisser, G
    Evertsz, CJ
    RADIOLOGY, 1997, 205 : 97 - 97
  • [28] Breast Cancer: Influence of Taxanes on Response Assessment with Dynamic Contrast-enhanced MR Imaging
    Schrading, Simone
    Kuhl, Christiane K.
    RADIOLOGY, 2015, 277 (03) : 687 - 696
  • [29] Combined quantitative dynamic contrast-enhanced MR imaging and 1H MR spectroscopic imaging of human prostate cancer
    van Dorsten, FA
    van der Graaf, M
    Engelbrecht, MRW
    van Leenders, GJLH
    Verhofstad, A
    Rijpkema, M
    de la Rosette, JJMCH
    Barentsz, JO
    Heerschap, A
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2004, 20 (02) : 279 - 287
  • [30] Contrast-enhanced dynamic MR imaging parameters and histological types of invasive ductal carcinoma of breast
    Takeda, Y
    Yoshikawa, K
    BIOMEDICINE & PHARMACOTHERAPY, 2005, 59 (03) : 115 - 121